Cargando…

Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells

Down syndrome (DS) is mostly caused by a trisomy of the entire Chromosome 21 (Trisomy 21, T21). Here, we use SWATH mass spectrometry to quantify protein abundance and protein turnover in fibroblasts from a monozygotic twin pair discordant for T21, and to profile protein expression in 11 unrelated DS...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yansheng, Borel, Christelle, Li, Li, Müller, Torsten, Williams, Evan G., Germain, Pierre-Luc, Buljan, Marija, Sajic, Tatjana, Boersema, Paul J., Shao, Wenguang, Faini, Marco, Testa, Giuseppe, Beyer, Andreas, Antonarakis, Stylianos E., Aebersold, Ruedi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663699/
https://www.ncbi.nlm.nih.gov/pubmed/29089484
http://dx.doi.org/10.1038/s41467-017-01422-6
_version_ 1783274859867930624
author Liu, Yansheng
Borel, Christelle
Li, Li
Müller, Torsten
Williams, Evan G.
Germain, Pierre-Luc
Buljan, Marija
Sajic, Tatjana
Boersema, Paul J.
Shao, Wenguang
Faini, Marco
Testa, Giuseppe
Beyer, Andreas
Antonarakis, Stylianos E.
Aebersold, Ruedi
author_facet Liu, Yansheng
Borel, Christelle
Li, Li
Müller, Torsten
Williams, Evan G.
Germain, Pierre-Luc
Buljan, Marija
Sajic, Tatjana
Boersema, Paul J.
Shao, Wenguang
Faini, Marco
Testa, Giuseppe
Beyer, Andreas
Antonarakis, Stylianos E.
Aebersold, Ruedi
author_sort Liu, Yansheng
collection PubMed
description Down syndrome (DS) is mostly caused by a trisomy of the entire Chromosome 21 (Trisomy 21, T21). Here, we use SWATH mass spectrometry to quantify protein abundance and protein turnover in fibroblasts from a monozygotic twin pair discordant for T21, and to profile protein expression in 11 unrelated DS individuals and matched controls. The integration of the steady-state and turnover proteomic data indicates that protein-specific degradation of members of stoichiometric complexes is a major determinant of T21 gene dosage outcome, both within and between individuals. This effect is not apparent from genomic and transcriptomic data. The data also reveal that T21 results in extensive proteome remodeling, affecting proteins encoded by all chromosomes. Finally, we find broad, organelle-specific post-transcriptional effects such as significant downregulation of the mitochondrial proteome contributing to T21 hallmarks. Overall, we provide a valuable proteomic resource to understand the origin of DS phenotypic manifestations.
format Online
Article
Text
id pubmed-5663699
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-56636992017-11-02 Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells Liu, Yansheng Borel, Christelle Li, Li Müller, Torsten Williams, Evan G. Germain, Pierre-Luc Buljan, Marija Sajic, Tatjana Boersema, Paul J. Shao, Wenguang Faini, Marco Testa, Giuseppe Beyer, Andreas Antonarakis, Stylianos E. Aebersold, Ruedi Nat Commun Article Down syndrome (DS) is mostly caused by a trisomy of the entire Chromosome 21 (Trisomy 21, T21). Here, we use SWATH mass spectrometry to quantify protein abundance and protein turnover in fibroblasts from a monozygotic twin pair discordant for T21, and to profile protein expression in 11 unrelated DS individuals and matched controls. The integration of the steady-state and turnover proteomic data indicates that protein-specific degradation of members of stoichiometric complexes is a major determinant of T21 gene dosage outcome, both within and between individuals. This effect is not apparent from genomic and transcriptomic data. The data also reveal that T21 results in extensive proteome remodeling, affecting proteins encoded by all chromosomes. Finally, we find broad, organelle-specific post-transcriptional effects such as significant downregulation of the mitochondrial proteome contributing to T21 hallmarks. Overall, we provide a valuable proteomic resource to understand the origin of DS phenotypic manifestations. Nature Publishing Group UK 2017-10-31 /pmc/articles/PMC5663699/ /pubmed/29089484 http://dx.doi.org/10.1038/s41467-017-01422-6 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Liu, Yansheng
Borel, Christelle
Li, Li
Müller, Torsten
Williams, Evan G.
Germain, Pierre-Luc
Buljan, Marija
Sajic, Tatjana
Boersema, Paul J.
Shao, Wenguang
Faini, Marco
Testa, Giuseppe
Beyer, Andreas
Antonarakis, Stylianos E.
Aebersold, Ruedi
Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells
title Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells
title_full Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells
title_fullStr Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells
title_full_unstemmed Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells
title_short Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells
title_sort systematic proteome and proteostasis profiling in human trisomy 21 fibroblast cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663699/
https://www.ncbi.nlm.nih.gov/pubmed/29089484
http://dx.doi.org/10.1038/s41467-017-01422-6
work_keys_str_mv AT liuyansheng systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells
AT borelchristelle systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells
AT lili systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells
AT mullertorsten systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells
AT williamsevang systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells
AT germainpierreluc systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells
AT buljanmarija systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells
AT sajictatjana systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells
AT boersemapaulj systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells
AT shaowenguang systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells
AT fainimarco systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells
AT testagiuseppe systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells
AT beyerandreas systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells
AT antonarakisstylianose systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells
AT aebersoldruedi systematicproteomeandproteostasisprofilinginhumantrisomy21fibroblastcells